Vaishali Deenadayalan

ORCID: 0000-0003-2482-0188 · 1 paper in corpus

observational 2026

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in malignant peritoneal mesothelioma (MPM).

·doi:10.1200/jco.2026.44.2_suppl.816

816 Background: MPM is a rare malignancy, with roughly 300 new cases in the United States annually. CRS-HIPEC has evolved as an important treatment nodality with demonstrated survival benefit. We studied the outcomes of MPM with CRS-HIPEC a…